List of Studies ( Metabolite:MG O-18:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST001041 | AN001706 | Development of a weaned pig model of enterotoxigenic E.coli-induced environmental enteropathy | Feces | Pig | Texas A&M University | - | |
| ST002228 | AN003637 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | abundance |
| ST002228 | AN003637 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Subcutaneous fat | Mouse | Obesity | Baker Heart and Diabetes Institute | abundance |
| ST002228 | AN003637 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | abundance |
| ST002370 | AN003865 | The impact of acute Colony Stimulating Factor 1 treatment on serum and liver metabolites in fed and fasted mice – SERUM | Blood | Mouse | Mater Research-The University of Queensland | area | |
| ST002348 | AN003833 | Comparative metabolite profiling of glycolytic and sulfoglycolytic E. coli | Bacterial cells | E. coli | University of Melbourne | a.u. | |
| ST000401 | AN000640 | Inhibition of diamine oxidase promotes uptake of putrescine from rat small intestine | Intestine | Rat | University of California, Davis | Counts | |
| ST000979 | AN001603 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial | Feces | Cat | Antibiotic resistance | University of California, Davis | Counts |
| ST000981 | AN001607 | Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part II) | Feces | Cat | Antibiotic resistance | University of California, Davis | Counts |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mus musculus | Diabetes | Monash Institute of Pharmaceutical Sciences | height |
| ST001133 | AN001858 | Downregulation of CENPF epigenetically remodels prostate cancer cells and alters cellular metabolism | Prostate | Human | Cancer | Cedars-Sinai Medical Center | Normalized intensity |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Blood | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Liver | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
| ST002026 | AN003296 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/GC) | Feces | Human | UC Davis | normalized peak height | |
| ST002585 | AN004257 | Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo | Epithelial cells | Rat | Cancer | West Coast Metabolomics Center | normalized peak heights |
| ST002825 | AN004609 | Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) | Brain | Human | Neurodegenerative disease | UC Davis | normalized peak heights |
| ST000241 | AN000373 | Cyclobutene- and cyclobutane-functionalized fatty acids as novel biochemical probes of structure and function in HepG2 cells | Cultured cells | Human | University of Nebraska-Lincoln | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001211 | AN002016 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University Of Kansas | Peak height | |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
| ST001282 | AN002126 | Role of Hi1a in mitochondrial metabolic rewiring in M1 Macrophages | Macrophages | Mouse | National Cancer Institute | Peak height normalized with creatinine | |
| ST001495 | AN002478 | Effects of Synbiotic Administration on Fecal Microbiome and Metabolomic Profiles of Dogs receiving Antibiotics | Feces | Dog | University of California, Davis | Peak height normalized with creatinine | |
| ST001700 | AN002771 | A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Serum) part-II | Blood | Mouse | National Institutes of Health | Peak height normalized with creatinine | |
| ST002556 | AN004211 | Blood metabolomics and impacted cellular mechanisms during transition into lactation in dairy cows that develop metritis | Blood | Cow | Infection | University of Florida | peak heights |
| ST002556 | AN004211 | Blood metabolomics and impacted cellular mechanisms during transition into lactation in dairy cows that develop metritis | Blood | Cow | Inflammation | University of Florida | peak heights |
| ST002801 | AN004557 | Investigation of metabolism in hypertrophic cardiomyopathy | Heart | Mouse | Heart disease | University of California, San Francisco | Peak Heights normalized by mTIC |
| ST000481 | AN001449 | Metabolomics of Mice Cohousing and Microbiota Transfer (part II) | Blood | Mouse | RTI International | Peak intensity |
